The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot

Author:

Loiseau Chloé,Windels Etthel M.ORCID,Gygli Sebastian M.,Jugheli Levan,Maghradze Nino,Brites DanielaORCID,Ross Amanda,Goig Galo,Reinhard Miriam,Borrell Sonia,Trauner Andrej,Dötsch Anna,Aspindzelashvili Rusudan,Denes Rebecca,Reither Klaus,Beisel ChristianORCID,Tukvadze Nestani,Avaliani Zaza,Stadler TanjaORCID,Gagneux SebastienORCID

Abstract

AbstractMultidrug-resistant tuberculosis (MDR-TB) is among the most frequent causes of death due to antimicrobial resistance. Although only 3% of global TB cases are MDR, geographical hotspots with up to 40% of MDR-TB have been observed in countries of the former Soviet Union. While the quality of TB control and patient-related factors are known contributors to such hotspots, the role of the pathogen remains unclear. Here we show that in the country of Georgia, a known hotspot of MDR-TB, MDR Mycobacterium tuberculosis strains of lineage 4 (L4) transmit less than their drug-susceptible counterparts, whereas most MDR strains of L2 suffer no such defect. Our findings further indicate that the high transmission fitness of these L2 strains results from epistatic interactions between the rifampicin resistance-conferring mutation RpoB S450L, compensatory mutations in the RNA polymerase, and other pre-existing genetic features of L2/Beijing clones that circulate in Georgia. We conclude that the transmission fitness of MDR M. tuberculosis strains is heterogeneous, but can be as high as drug-susceptible forms, and that such highly drug-resistant and transmissible strains contribute to the emergence and maintenance of hotspots of MDR-TB. As these strains successfully overcome the metabolic burden of drug resistance, and given the ongoing rollout of new treatment regimens against MDR-TB, proper surveillance should be implemented to prevent these strains from acquiring resistance to the additional drugs.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference71 articles.

1. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Wellcome Trust & HM Government, UK (2014).

2. Antimicrobial Resistance C. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet, (2022).

3. World Health Organization. Global tuberculosis control - surveillance, planning, financing. WHO (2022).

4. Brown, H. WHO identifies drug-resistant tuberculosis “hotspots”. Lancet 363, 951 (2004).

5. Dye, C., Williams, B. G., Espinal, M. A. & Raviglione, M. C. Erasing the world’s slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295, 2042–2046 (2002).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3